| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026467 |
| Receipt No. | R000030368 |
| Official scientific title of the study | An evaluation of CapnostreamTM for contribution to the safety in patients undergoing sedation for endoscopy |
| Date of disclosure of the study information | 2017/03/10 |
| Last modified on | 2018/03/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | An evaluation of CapnostreamTM for contribution to the safety in patients undergoing sedation for endoscopy | |
| Title of the study (Brief title) | The utility of CapnostreamTM in patients undergoing sedation for endoscopy | |
| Region |
|
|
| Condition | ||
| Condition | pancreatobiliary disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study evaluated the utility of CapnostreamTM as a monitor for respiratory depression in patients undergoing sedation for pancreatobiliary endoscopy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Integrated pulmonary indexTM calculated with CapnostreamTM in patients undergoing sedation for pancreatobiliary endoscopy. |
| Key secondary outcomes | 1.Comparison and association between Integrated pulmonary indexTM and oxygen saturation.
2.Comparison and association between Integrated pulmonary indexTM and end-tidal carbon dioxide. 3.Comparison and association between Integrated pulmonary indexTM and respiratory rate. 4.The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of Integrated pulmonary indexTM for respiratory depression. 5.Adverse events during this study. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with the necessity of pancreatobiliary endoscopy
2.Patients who is American Society of Anesthesiologists physical status I-III 3. Patients who participated oneself with enough understanding after receiving enough explanation |
|||
| Key exclusion criteria | 1. Patients who is American Society of Anesthesiologists physical status 4 or 5
2. Patients who is unable to give informed consent 3. Patients required monitored anesthesia care sedation 4. Patients used oxygen or noninvasive ventilation devices before the procedure 5. patients who had allergies to midazolam |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Hirofumi Yamanishi |
| Organization | Kinan Hospital |
| Division name | Gastroenterology |
| Address | Shinjo-cho46-70, Tanabe, Wakayama |
| TEL | 0739-22-5000 |
| hiroyamanishi0925@gmail.com | |
| Public contact | |
| Name of contact person | Hirofumi Yamanishi |
| Organization | Kinan Hospital |
| Division name | Gastroenterology |
| Address | Shinjo-cho46-70, Tanabe, Wakayama |
| TEL | 0739-22-5000 |
| Homepage URL | |
| hiroyamanishi0925@gmail.com | |
| Sponsor | |
| Institute | Department of Gastroenterology, Kinan Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 紀南病院(和歌山県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | Prospective cohort study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030368 |